BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27226597)

  • 1. Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins.
    Knyphausen P; de Boor S; Kuhlmann N; Scislowski L; Extra A; Baldus L; Schacherl M; Baumann U; Neundorf I; Lammers M
    J Biol Chem; 2016 Jul; 291(28):14677-94. PubMed ID: 27226597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays to Study Enzymatic and Non-Enzymatic Protein Lysine Acetylation In Vitro.
    Graf LG; Vogt R; Blasl AT; Qin C; Schulze S; Zühlke D; Sievers S; Lammers M
    Curr Protoc; 2021 Nov; 1(11):e277. PubMed ID: 34748287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms.
    Rauh D; Fischer F; Gertz M; Lakshminarasimhan M; Bergbrede T; Aladini F; Kambach C; Becker CF; Zerweck J; Schutkowski M; Steegborn C
    Nat Commun; 2013; 4():2327. PubMed ID: 23995836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.
    Smith BC; Denu JM
    J Biol Chem; 2007 Dec; 282(51):37256-65. PubMed ID: 17951578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based mechanism of ADP-ribosylation by sirtuins.
    Hawse WF; Wolberger C
    J Biol Chem; 2009 Nov; 284(48):33654-61. PubMed ID: 19801667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
    Smith BC; Denu JM
    Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting sirtuin-catalyzed deacylation reactions using ³²P-labeled NAD and thin-layer chromatography.
    Zhu A; Su X; Lin H
    Methods Mol Biol; 2013; 1077():179-89. PubMed ID: 24014407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.
    Feldman JL; Dittenhafer-Reed KE; Kudo N; Thelen JN; Ito A; Yoshida M; Denu JM
    Biochemistry; 2015 May; 54(19):3037-3050. PubMed ID: 25897714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
    Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
    J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
    Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
    Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins.
    Feldman JL; Baeza J; Denu JM
    J Biol Chem; 2013 Oct; 288(43):31350-6. PubMed ID: 24052263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDAC8 substrate specificity quantified by a biologically relevant, label-free deacetylation assay.
    Toro TB; Watt TJ
    Protein Sci; 2015 Dec; 24(12):2020-32. PubMed ID: 26402585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.
    Zheng W
    Mini Rev Med Chem; 2013 Jan; 13(1):132-54. PubMed ID: 22876953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E. coli sirtuin CobB shows no preference for enzymatic and nonenzymatic lysine acetylation substrate sites.
    AbouElfetouh A; Kuhn ML; Hu LI; Scholle MD; Sorensen DJ; Sahu AK; Becher D; Antelmann H; Mrksich M; Anderson WF; Gibson BW; Schilling B; Wolfe AJ
    Microbiologyopen; 2015 Feb; 4(1):66-83. PubMed ID: 25417765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates.
    Song HY; Park SH; Kang HJ; Vassilopoulos A
    J Vis Exp; 2016 Feb; (108):53563. PubMed ID: 26966987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases.
    Hallows WC; Lee S; Denu JM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10230-10235. PubMed ID: 16790548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-Fluorenylmethoxycarbonyl-labeled peptides as substrates in a capillary electrophoresis-based assay for sirtuin enzymes.
    Fan Y; Ludewig R; Scriba GK
    Anal Biochem; 2009 Apr; 387(2):243-8. PubMed ID: 19454228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS/MS-based quantitative study of the acyl group- and site-selectivity of human sirtuins to acylated nucleosomes.
    Tanabe K; Liu J; Kato D; Kurumizaka H; Yamatsugu K; Kanai M; Kawashima SA
    Sci Rep; 2018 Feb; 8(1):2656. PubMed ID: 29422688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of human SIRT3 displaying substrate-induced conformational changes.
    Jin L; Wei W; Jiang Y; Peng H; Cai J; Mao C; Dai H; Choy W; Bemis JE; Jirousek MR; Milne JC; Westphal CH; Perni RB
    J Biol Chem; 2009 Sep; 284(36):24394-405. PubMed ID: 19535340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CobB kinetics and inhibition by nicotinamide.
    Gallego-Jara J; Écija Conesa A; de Diego Puente T; Lozano Terol G; Cánovas Díaz M
    PLoS One; 2017; 12(12):e0189689. PubMed ID: 29253849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.